Oncolytic Virus Therapy Shows Promising Results in Early-Stage TNBC
February 22nd 2023Results from a phase 2 study suggests that the oncolytic virus talimogene laherparepvec has potential to improve therapy responses for patients undergoing neoadjuvant chemotherapy for triple-negative breast cancer (TNBC).
Read More
Telementoring Program Linked With Improvement in Epilepsy Care Among School Nurses
February 22nd 2023School nurses reported improved knowledge and confidence in the care of students with seizures after undergoing the Project ECHO (Extension for Community Healthcare Outcomes) telementoring program for epilepsy.
Read More
Merck’s COVID-19 pill has been shown to not be successful against household infection risk; the government plans to allow states to use Medicaid funds for prison drug treatment and other services; Ozempic, used to treat type 2 diabetes, is in short supply because it’s being sought for weight loss.
Read More
Andexanet Alfa Fully Neutralizes Anticoagulation From Thrombotic Disorder Treatment
February 22nd 2023Researchers found that the anticoagulant effects of apixaban, betrixaban, edoxaban, and rivaroxaban were partially neutralized at an andexanet alfa dose of 50 mcg/mL and were completely neutralized at 100 mcg/mL.
Read More
Mental Health Care Is Challenged by Inaccurate, Inadequate Provider Directories
February 21st 2023On this episode of Managed Care Cast, we speak with Simon F. Haeder, PhD, MPA, professor of public health at the Texas A&M University School of Public Health. He and his co-investigators looked at the accuracy of directories of psychiatrists and nonphysician mental health providers for all plans regulated by the California Department of Managed Health Care in 2018 and 2019.
Listen
Diagnostic Efficacy of Frequent Acute Exacerbations Investigated in Patients With COPD
February 21st 2023Imaging and clinical characteristics reach high diagnostic efficacy when they are used to identify frequent acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Read More
Joneigh Khaldun, MD, MPH, FACEP, vice president and chief health equity officer for CVS Health, speaks on the goals of the Community Equity Alliance in improving health care disparities, particularly for cardiovascular health and mental health outcomes, within underserved communities.
Watch
Retinal Physicians Report Reservations Around Ophthalmology Biosimilars
February 20th 2023There are 2 ranibizumab biosimilars approved in the United States, and with more ranibizumab and the first aflibercept biosimilars on the horizon, gaps in knowledge among retinal physicians should be addressed.
Read More
Spleen Response Closely Linked With Survival in MF While on Ruxolitinib
February 20th 2023Patients with myelofibrosis (MF) who achieved a spleen response while taking ruxolitinib and lost it had survival outcomes similar to patients who did not respond, according to results from a real-world study.
Read More
Study Characterizes Real-World Use of Relugolix in Combination With Other Prostate Cancer Therapies
February 19th 2023Relugolix was frequently used in combination with other medications for prostate cancer in patients both new to androgen-deprivation therapy and continuing androgen-deprivation therapy in a real-world study.
Read More
Telehealth Involves More Than Making a Phone Call, Says Oncology Consultants’ Wagner
February 19th 2023We’ve found through health equity initiatives that the search for the right telehealth modality is never ending, explained Oncology Consultants of Houston’s Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy.
Watch
NGS-Based Assay Shows Feasibility, Potential Cost Savings in Newborn SMA Screening
February 18th 2023Investigators note that although the overall cost for implementing next-generation sequencing (NGS) testing would be more than implementing current polymerase chain reaction (PCR)–based testing, the assay may be more cost effective overall because it screens for multiple conditions.
Read More
Study Suggests Second-line Axi-Cel Is Cost-effective vs Standard Care in R/R DLBCL
February 18th 2023Despite coming at a high cost, an analysis found that in some cases, chimeric antigen receptor T-cell therapy may be cost-effective compared with the standard of care in the second line or later for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
Read More
Early CPAP and HNFC Intervention Reduces Intubation and Mortality Rates After COVID-19 Infection
February 17th 2023Patients with acute respiratory distress syndrome (ARDS) second to COVID-19 improved with early continuous positive airway pressure (CPAP) and high-flow nasal cannula (HFNC) treatment, a study finds.
Read More
Postdischarge Telemonitoring, Telephone Coaching May Benefit Certain Patients With Heart Failure
February 17th 2023Patients with heart failure and high comorbidity burdens who received postdischarge noninvasive telemonitoring and nurse telephone coaching showed better survival outcomes than those who received standard care.
Read More